Kiniksa Announces Commercial Availability of ARCALYST ® (rilonacept) for Recurrent Pericarditis
- ARCALYST is the first and only FDA-approved therapy for recurrent pericarditis –- ARCALYST now available on prescription basis in...
Year: 2021
Augmedix’s Proprietary Notebuilder Tool Leverages Intelligent Automation Technology to Efficiently Deliver Accurate and Timely Medical Notes
Leader in Virtual Medical Documentation and Live Clinical Support Enhances Technology Behind Artificial Intelligence and Human-in-the-Loop SolutionSAN FRANCISCO, April 01,...
F-star Therapeutics Announces Third Option Exercised by Merck KGaA, Darmstadt, Germany in Immuno-Oncology Collaboration
CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., April 01, 2021 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical...
Cidara Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, April 01, 2021 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics designed to transform...
Recce Pharmaceuticals Announces Positive Data Against Streptococcus pneumoniae Sinusitis Infection in Animal Model
Efficacy of Recce Anti-Infectives in Acute Bacterial Rhinosinusitis Efficacy Acute Bacterial Rhinosinusitis Histology of Sinuses in Acute Bacterial Rhinosinusitis Animal...
Arbor Biotechnologies Names Devyn Smith, Ph.D., as CEO
CAMBRIDGE, Mass., April 01, 2021 (GLOBE NEWSWIRE) -- Arbor Biotechnologies, an early-stage life sciences company unlocking nature’s genetic diversity to...
Psirenity signs partnership with Jamaica’s Scientific Research Council to conduct joint studies into beneficial effects of psilocybin mushrooms
TORONTO, April 01, 2021 (GLOBE NEWSWIRE) -- Psirenity, a wholly owned subsidiary of New Leaf Canada Inc., today announced it...
Excision BioTherapeutics Appoints Biotechnology Industry Research & Development Veteran, William Kennedy, M.D., as Senior Vice President, Clinical Development
SAN FRANCISCO, April 01, 2021 (GLOBE NEWSWIRE) -- Excision BioTherapeutics (“Excision”), a leading developer of potentially curative CRISPR anti-viral therapies...
LAVA Therapeutics Appoints Karen J. Wilson to its Board of Directors
UTRECHT, The Netherlands and PHILADELPHIA, April 01, 2021 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (Nasdaq: LVTX), a biotechnology company focused...
Eloxx Pharmaceuticals Acquires Zikani Therapeutics
Combined Company to be Leader in Ribosomal RNA-Targeted Genetic Therapy Bringing Together Complementary Platforms Maximizes Potential for ELX-02 for Cystic...
Progressive Care Announces 2020 Annual and Quarterly Financial and Operational Performance Highlights
MIAMI, FL, April 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”),...
Acerus Buys Back All Remaining U.S. Rights for NATESTO® From Aytu
Acerus Assumes Full NATESTO Ownership from Aytu BioPharma, Accelerating Path to Becoming Fully Integrated Specialty Pharmaceutical CompanyTORONTO, April 01, 2021...
Inozyme Pharma Expands its Scientific Advisory Board
- Appoints veteran leaders with deep scientific and clinical expertise in vascular calcification, renal disease, and diseases with neointimal proliferation...
Milestone Scientific Provides 2020 Year-End Business Update; Reports a 78% Sequential Increase in Revenue for Q4 2020 Versus Q3 2020
Milestone Scientific Reports Continued Progress on Commercial Rollout of CompuFlo Epidural SystemROSELAND, N.J., April 01, 2021 (GLOBE NEWSWIRE) -- Milestone...
Arbutus Biopharma, X-Chem and Proteros biostructures Enter into a Pan-Coronavirus Discovery Research and License Agreement
Collaboration formed to accelerate the discovery of novel oral inhibitors targeting the SARS-CoV-2 nsp5 main protease for the treatment of...
G1 Therapeutics to Host Virtual COSELA™ (trilaciclib) Kickoff Analyst and Investor Summit on April 9, 2021
RESEARCH TRIANGLE PARK, N.C., April 01, 2021 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today...
European Pharmaceutical Company STADA and MediPharm Labs Begin First Sales in Germany Under Exclusive Agreement
BARRIE, Ontario, April 01, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs”) a...
COMPASS Pathways appoints Wayne J Riley MD to its Board of Directors
COMPASS Pathways appoints Wayne J Riley MD to its Board of Directors London, UK – 1 April 2021 COMPASS Pathways...
Altimmune Reports Data from its Phase 1b Clinical Trial of NasoShield™
GAITHERSBURG, Md., April 01, 2021 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, reported clinical data today...
Baudax Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
MALVERN, Pa., April 01, 2021 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (Nasdaq: BXRX), a pharmaceutical company focused on therapeutics for...